Jan Tennvall

Guidelines for radioiodine therapy of differentiated thyroid cancer

Markus Luster, Sharon E. Clarke, Markus Dietlein et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2008 · 710 citations

Medicine, Radionuclide Therapy, Thyroid Disease +7

Bone-targeted radium-223 in symptomatic, hormone-refractory prostate cancer: a randomised, multicentre, placebo-controlled phase II study

Sten Nilsson, Lars Franzén, Christopher Parker et al. · The Lancet Oncology · 2007 · 491 citations

Bone-targeted Radium-223, Urology, Genitourinary Cancer +6

Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial

Sophie Leboulleux, Lars Bastholt, Thomas Krause et al. · The Lancet Oncology · 2012 · 371 citations

Medicine, Thyroid Disease, Cancer Treatment +6

Cancer Risk After Iodine-131 Therapy for Hyperthyroidism

Lars‐Erik Holm, Peter Hall, K Wiklund et al. · JNCI Journal of the National Cancer Institute · 1991 · 268 citations

FDG PET studies during treatment: Prediction of therapy outcome in head and neck squamous cell carcinoma

Eva Brun, Elisabeth Kjellén, Jan Tennvall et al. · Head & Neck · 2002 · 250 citations